Implications of Hepatitis B Virus Genomic Variations on Treatment Outcomes

E-ISSN： 1875-6913|8|4|280-288

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.8, Iss.4, 2010-12, pp. : 280-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis B virus drug resistance: mechanism and clinical implications for the prevention of treatment failure

By Zoulim Fabien Lucifora Julie

Future Virology, Vol. 1, Iss. 3, 2006-05 ,pp. : 361-376

Future Medicine

Access to resources Recommend Favorite

Clevudine for the treatment of chronic hepatitis B virus infection

By Hui Chee-Kin Lau George KK

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 10, 2005-10 ,pp. : 1277-1284

Informa Healthcare

Access to resources Recommend Favorite

New Treatment Targets and Approaches for Hepatitis B Virus

Anti-Infective Agents, Vol. 15, Iss. 1, 2017-04 ,pp. : 4-8

Bentham Science Publishers

Access to resources Recommend Favorite

Entecavir for the treatment of patients with hepatitis B virus-related decompensated cirrhosis

By Sadler Matthew D Coffin Carla S Lee Samuel S

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1363-1369

Informa Healthcare

Access to resources Recommend Favorite

Evolving therapies for the treatment of chronic hepatitis B virus infection

By IV William E Delaney Bartholomeusz Angeline Locarnini Stephen A

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 2, 2002-02 ,pp. : 169-187

Informa Healthcare

Access to resources Recommend Favorite